Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial

Pagano, Gennaro; Monnet, Annabelle; Reyes, Adriana; Ribba, Benjamin; Svoboda, Hanno; Kustermann, Thomas; Simuni, Tanya; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Brockmann, Kathrin; Smigorski, Krzysztof; Gerbaldo, Valentina; Fontoura, Paulo; Doody, Rachelle; Kerchner, Geoffrey A.; Brundin, Patrik; Marek, Kenneth; Bonni, Azad; Nikolcheva, Tania

dc.contributor.author	Brockmann, Kathrin
dc.date.accessioned	2025-05-26T10:19:08Z
dc.date.available	2025-05-26T10:19:08Z
dc.date.issued	2024
dc.identifier.issn	1078-8956
dc.identifier.uri	http://hdl.handle.net/10900/165923
dc.language.iso	en	de_DE
dc.publisher	Berlin : Nature Portfolio	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41591-024-03270-6	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250203000000_00951
utue.publikation.seiten	3669–3675	de_DE
utue.personen.roh	Pagano, Gennaro
utue.personen.roh	Monnet, Annabelle
utue.personen.roh	Reyes, Adriana
utue.personen.roh	Ribba, Benjamin
utue.personen.roh	Svoboda, Hanno
utue.personen.roh	Kustermann, Thomas
utue.personen.roh	Simuni, Tanya
utue.personen.roh	Postuma, Ronald B.
utue.personen.roh	Pavese, Nicola
utue.personen.roh	Stocchi, Fabrizio
utue.personen.roh	Brockmann, Kathrin
utue.personen.roh	Smigorski, Krzysztof
utue.personen.roh	Gerbaldo, Valentina
utue.personen.roh	Fontoura, Paulo
utue.personen.roh	Doody, Rachelle
utue.personen.roh	Kerchner, Geoffrey A.
utue.personen.roh	Brundin, Patrik
utue.personen.roh	Marek, Kenneth
utue.personen.roh	Bonni, Azad
utue.personen.roh	Nikolcheva, Tania
dcterms.isPartOf.ZSTitelID	Nature Medicine	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	30	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE